TP
TECH icon

Truvvo Partners’s Bio-Techne TECH Stock Holding History

Truvvo Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,580
Closed -$634K – 118
2017
Q4 		$634K Hold
19,580
– – 0.21% 88
2017
Q3 		$592K Hold
19,580
– – 0.2% 90
2017
Q2 		$574K Hold
19,580
– – 0.21% 91
2017
Q1 		$498K Sell
19,580
-840
-4% -$21.7K 0.22% 86
2016
Q4 		$525 Hold
20,420
– – 0.18% 91
2016
Q3 		$559K Hold
20,420
– – 0.25% 84
2016
Q2 		$576K Hold
20,420
– – 0.3% 72
2016
Q1 		$483K Buy
20,420
+6,984
+52% +$154K 0.22% 86
2015
Q4 		$302K Buy
+13,436
New +$306K 0.16% 98

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Truvvo Partners's TECH Position: Q1 2018 in Review

Truvvo Partners sold out of Bio-Techne (TECH) in Q1 2018, closing a stake of 19,580 shares — an estimated $634K sold.

Truvvo Partners first reported a position in TECH in Q4 2015 and held it in 9 quarters. The position peaked at $634K in Q4 2017. 332 funds tracked by Wall St. Rank hold TECH as of Q1 2018.

  • Truvvo Partners reported no remaining Bio-Techne position as of Q1 2018 after selling out during the quarter.
  • Truvvo Partners sold 19,580 Bio-Techne shares in Q1 2018, an estimated $634K.
  • Truvvo Partners first reported a position in Bio-Techne in Q4 2015 and held it in 9 quarters.
  • Truvvo Partners's Bio-Techne position peaked at $634K in Q4 2017.
  • 332 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2018.

Based on Truvvo Partners's 13F filing for Q1 2018, filed 15 May 2018.